This study firstly proved that MARCH5 played a protective role in maintaining ECs function under hypoxic stress by regulating Akt/eNOS signalling, which might be a potential therapeutic target for the clinical management of ischemic heart diseases. The gene discussed is MARCHF5; the disease is coronary artery disorder.